Navigation Links
GranuFlo Lawsuit News: Bernstein Liebhard LLP Notes Recent Surge of FDA Drug Recalls
Date:8/14/2014

New York, NY (PRWEB) August 14, 2014

A U.S. Food and Drug Administration (FDA) initiative that allows public access to product recall information reveals that actions similar to one that has since prompted thousands of GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) have increased dramatically over the past few years, Bernstein Liebhard LLP reports.

According to a recent report from the Regulatory Affairs Professionals Society, a total of 499 drug recalls were issued by the FDA in 2012; the same year a Class I recall of GranuFlo and NaturaLyte, two acid concentrates used in dialysis, was announced. The FDA issued more than 1,220 recalls in 2013, and another 836 have already been announced in 2014, according to an article published on August 11th.*

Following the GranuFlo recall of 2012, court documents show thousands of lawsuits now filed on behalf of individuals who received the dialysis medications, which are distributed by Fresenius Medical Care. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

“As product recalls continue to be announced by the FDA, our Firm continues to hear from individuals who suffered injuries allegedly caused by dialysis medications affected by the 2012 GranuFlo recall,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who were allegedly injured by products affected by the 2012 GranuFlo and NaturaLyte recall, as well as others involved in similar recalls.

GranuFlo Lawsuits

In June 2012, the FDA granted a Class I recall of GranuFlo and NaturaLyte after determining that use of the dialysis drugs may pose a risk of serious injury or death. This action followed an Urgent Product Notification issued by Fresenius two months earlier that noted its products’ potential to cause serious cardiovascular problems. Since then, thousands of GranuFlo and NaturaLyte lawsuits were filed on behalf of individuals who allegedly suffered cardiac arrest, heart attacks, strokes, sudden cardiac death and other side effects caused by the dialysis medications. The majority of claims have now been centralized in the U.S. District Court, District of Massachusetts, where a multidistrict litigation has been established.

GranuFlo recall lawsuits now filed in Massachusetts accuse Fresenius of failing to adequately warn dialysis patients about the potential for its products to cause serious heart problems that may turn fatal. Plaintiffs further allege that the company continued to aggressively market GranuFlo and NaturaLyte even after it became aware of its potential to cause harm to patients.

In addition to Fresenius lawsuits now filed in the District of Massachusetts, court records indicate that nearly 4,000 claims have been consolidated at the state court level in Middlesex County Superior Court. (In re: Consolidated Fresenius Cases, No. MICV2013-03400-O).

Individuals who were allegedly harmed by GranuFlo or NaturaLyte may be eligible to file their own lawsuit against Fresenius. Learn more (http://www.thegranuflolawsuit.com/granuflo-dialysis-recall/) about the FDA’s GranuFlo recall of 2012 by visiting Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.

*raps.org/Regulatory-Focus/News/2014/08/11/20005/Number-of-Drug-Recalls-Surges-at-FDA-Led-by-Mid-Level-Concerns/; Regulatory Affairs Professional Society, August 11, 2014.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.thegranuflolawsuit.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/granuflo-lawsuit/granuflo-recall/prweb12096580.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports
2. Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs
3. GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports
4. GranuFlo Lawsuit Filings Near 2,000 in Federal Massachusetts Litigation Two Years after Dialysis Recall, Bernstein Liebhard LLP Reports
5. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
6. GranuFlo Lawsuits Move Forward, as Federal Court Adopts Master Complaint for all Claims Filed in Wake of GranuFlo and NaturaLyte Recall, Bernstein Liebhard LLP Reports
7. Federal GranuFlo Lawsuits Move Forward with Scheduling of First Status Conference of the New Year, Bernstein Liebhard LLP Reports
8. Bernstein Liebhard LLP Publishes New GranuFlo Lawsuit Website for Individuals Allegedly Affected by 2012 Dialysis Drug Recall
9. GranuFlo Lawsuit News: Bernstein Liebhard LLP Notes Filing of New Joint Motion in Federal GranuFlo Recall Litigation
10. More Than 430 Cases Now Filed in Federal GranuFlo Lawsuit Litigation, Bernstein Liebhard LLP Continues to Investigate Dialysis Claims
11. Bernstein Liebhard LLP Launches New GranuFlo Lawsuit Website for Individuals Allegedly Injured by Recalled Dialysis Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... Atlanta, GA (PRWEB) , ... April 25, 2017 , ... ... to their neck and back pain with a reputable physician in their area, announces ... The CRM protects patient information for patients who are looking for reputable physicians to ...
(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
(Date:4/24/2017)... ... 24, 2017 , ... Michael Vick announced his retirement earlier this year from ... overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, made ... the most career rushing yards by a quarterback (6,109) and the most rushing yards ...
(Date:4/24/2017)... ... , ... The bar for just about everything—apparel, eyewear, cars and even phone ... pop and film stardom.(1) Not to be left out is that most desired of ... the gamut from being encrusted with jewels and precious metals to, at the very ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... Solentim, the developer of instrumentation for ... a major new product line called the VIPS™ ... has been developed for automatically seeding single cells ... of the process to generate clonally-derived cell lines. ... reliable solution when compared to traditional single cell ...
(Date:4/20/2017)... April 20, 2017  Vivify Health, the pioneer and ... been awarded a very significant patent for the advancement ... continual care via digital health.  This landmark patent provides ... and further secures Vivify,s position as the leader in ... was the first company to apply consumer mobile devices, ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
Breaking Medicine Technology: